Clinical electromyomechanographic and electromyographic studies in decurarization with pymadine.
The authors present a clinical evaluation of a new drug - pymadine - reversing the non-depolarization block. The drug was administered to 21 patients. Full return of neuromuscular conduction was obtained. The drug is not an anticholinergic agent, has no side effects and does not require atropine administration. The authors recommend its use in patients with high cardiovascular and respiratory operative risk.